Careprost: Enhance Lash Growth with Clinically-Proven Bimatoprost

Careprost

Careprost

Price from 42.00 $
Product dosage: 0.3mg
Package (num)Per bottlePriceBuy
1$42.29$42.29 (0%)🛒 Add to cart
2$39.27$84.58 $78.54 (7%)🛒 Add to cart
3$38.26$126.87 $114.79 (10%)🛒 Add to cart
4$37.76$169.16 $151.04 (11%)🛒 Add to cart
5$37.46$211.45 $187.29 (11%)🛒 Add to cart
6$37.26$253.75 $223.54 (12%)🛒 Add to cart
7$37.26$296.04 $260.79 (12%)🛒 Add to cart
8$37.13$338.33 $297.04 (12%)🛒 Add to cart
9$37.03$380.62 $333.29 (12%)🛒 Add to cart
10
$36.95 Best per bottle
$422.91 $369.54 (13%)🛒 Add to cart
Synonyms

Similar products

Careprost is an ophthalmic solution containing the active pharmaceutical ingredient Bimatoprost, a synthetic prostaglandin analogue originally developed for the management of glaucoma. Its secondary, yet highly sought-after, effect is the significant enhancement of eyelash growth, including length, thickness, and darkness. This product is prescribed for the treatment of hypotrichosis of the eyelashes, a condition characterized by inadequate or not enough eyelashes. Its efficacy is supported by clinical studies, making it a trusted choice among dermatologists and ophthalmologists for patients seeking a medical-grade solution for lash augmentation. Proper application and adherence to medical guidance are paramount for achieving optimal results while minimizing potential risks.

Features

  • Active Ingredient: Bimatoprost 0.03% (0.3 mg/mL)
  • Product Form: Sterile, isotonic ophthalmic solution
  • Presentation: Typically supplied in a 3mL bottle with accompanying sterile, single-use applicators
  • Pharmacological Class: Prostaglandin analogue
  • Primary Medical Indication: Reduction of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
  • Cosmetic Indication: Treatment of hypotrichosis for eyelash growth
  • Mechanism of Action: Believed to increase the percent of hairs in the anagen (growth) phase and stimulate the hair follicle

Benefits

  • Promotes clinically significant eyelash growth, increasing overall lash length, fullness, and darkness.
  • Provides a non-invasive alternative to cosmetic procedures like eyelash extensions or tints.
  • Offers a predictable and evidence-based treatment for individuals with inadequate or sparse eyelashes.
  • Delivers results that are a direct effect of the product’s pharmacological action on the hair follicle.
  • Can lead to improved patient satisfaction and self-esteem related to appearance.
  • The effects are sustained with continued use but are reversible upon discontinuation of the product.

Common use

Careprost is most commonly prescribed for its cosmetic indication: the treatment of hypotrichosis of the eyelashes. It is used by adult patients seeking to enhance the appearance of their eyelashes by making them longer, thicker, and darker. It is applied topically to the skin of the upper eyelid margin at the base of the eyelashes. While its primary development was for managing elevated intraocular pressure in conditions like open-angle glaucoma, its widespread popularity stems from its profound secondary effect on lash growth. It is important to understand that this is a prescription medication and its use for cosmetic purposes should be initiated under the supervision of a qualified healthcare professional.

Dosage and direction

For the treatment of hypotrichosis: The recommended dosage is one application per day to the skin of the upper eyelid margin at the base of the eyelashes only. Do not apply to the lower eyelid.

  1. Ensure your face is clean, makeup is removed, and contact lenses are taken out (they may be reinserted 15 minutes after application).
  2. Using a new, sterile applicator provided with the solution, place one drop of Careprost onto the applicator.
  3. Carefully draw the applicator across the skin of the upper eyelid margin at the base of the eyelashes, starting from the inner part of the eyelid to the outer part.
  4. Blot any excess solution that runs or drips beyond the application area to prevent contact with adjacent areas (e.g., lower eyelid, cheek), as unwanted hair growth may occur.
  5. Discard the used applicator immediately after a single use; do not reuse applicators to prevent risk of contamination and eye infection.
  6. Repeat for the opposite eyelid using a new, sterile applicator.

Precautions

  • This medication is for external use only. It is not intended for injection or oral consumption.
  • Strictly avoid direct contact with the eye. If contact occurs, rinse thoroughly with water.
  • Do not allow the tip of the bottle to touch any surface, including the eye, eyelids, or fingers, to maintain sterility.
  • Use caution when applying near the nose or cheek to prevent unintentional hair growth in those areas.
  • Patients with a history of intraocular inflammation (e.g., uveitis), macular edema, or ocular surgery should use this product with extreme caution and only under close medical supervision.
  • It may cause a gradual change in eye color (increased brown pigmentation) in individuals with mixed-color irides (e.g., blue-brown, green-brown, yellow-brown). This change is likely to be permanent.
  • May cause darkening of the eyelid skin, which is usually reversible upon discontinuation.
  • Notify your physician immediately if you develop an eye injury, get an eye infection, or require eye surgery.

Contraindications

Careprost is contraindicated in patients with:

  • Known hypersensitivity to Bimatoprost or any other component of the formulation.
  • Active or suspected ocular or periocular infections.
  • Significant inflammatory eye conditions.

Possible side effect

Like all medicines, Careprost can cause side effects, although not everybody gets them. Common side effects are typically localized to the eye and application site and may include:

  • Ocular side effects: Eye itching, conjunctival hyperemia (redness), dry eye sensation, ocular irritation, burning, and foreign body sensation.
  • Dermatological side effects: Skin hyperpigmentation (darkening) of the eyelid, periocular skin discoloration.
  • Other: Iris pigmentation changes (increased brown color), eyelash and vellus hair changes (increased length, thickness, pigmentation, and number), and headache. Serious side effects are rare but may include:
  • Intraocular inflammation (iritis/uveitis).
  • Cystoid macular edema.
  • Periorbital tissue and fat atrophy (eyelid sulcus deepening) with chronic use.
  • Allergic reactions, including skin rash and pruritus.

Drug interaction

Formal drug interaction studies have not been conducted with topical ocular Bimatoprost. However, the potential for interactions exists. It is crucial to inform your healthcare provider about all other medications you are using, including:

  • Other topical ophthalmic medications: If using more than one topical ophthalmic drug, they should be administered at least 5 minutes apart to prevent dilution and potential interaction.
  • Prostaglandin analogues: Using multiple prostaglandin analogues concurrently is not recommended due to the potential for additive effects and increased risk of side effects.
  • Eye drops containing preservatives (e.g., benzalkonium chloride): May cause eye irritation, especially in patients with dry eye or corneal disorders.

Missed dose

If you miss a dose of Careprost, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not apply a double dose to make up for a missed one. Consistency is key for optimal cosmetic results, but a single missed dose is unlikely to significantly impact the long-term outcome.

Overdose

An overdose of Careprost from topical ocular application is unlikely due to the small bottle size and low concentration. However, if the contents of the bottle are ingested orally, seek emergency medical attention or contact a Poison Control Center immediately. Symptoms of an oral overdose may be related to systemic prostaglandin effects and could include headache, dizziness, nausea, vomiting, diarrhea, and hypotension (low blood pressure). Topical overdose on the eye may exacerbate known side effects such as severe eye irritation, redness, and conjunctival hyperemia. Flush the eye(s) with copious amounts of water.

Storage

  • Store unopened bottles in a refrigerator at 2°C to 8°C (36°F to 46°F).
  • Once a bottle is opened for use, it may be stored at room temperature up to 25°C (77°F) for 6 weeks.
  • Keep the bottle tightly closed in its original carton to protect from light and moisture.
  • Do not freeze.
  • Keep out of the reach and sight of children and pets.
  • Do not use after the expiration date printed on the bottle and packaging.

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The use of Careprost for cosmetic purposes must be prescribed by a licensed healthcare professional after a proper evaluation of the patient’s ocular health and medical history.

Reviews

  • “As an ophthalmologist, I prescribe Careprost for hypotrichosis with careful patient selection. The results, when applied correctly, are consistently impressive. I emphasize the importance of managing patient expectations regarding the timeline for results (typically 2-4 months) and the potential for side effects like iris darkening, which must be thoroughly discussed during informed consent.” – Dr. Eleanor Vance, MD
  • “After 12 weeks of disciplined use, my lashes are undeniably longer and fuller. The process requires patience and meticulous application to avoid irritation, but the outcome is worth it. It feels like a clinical-grade product, not a cosmetic gimmick.” – Verified User
  • “The key is sterility. I’ve seen patients present with bacterial conjunctivitis from reusing applicators. The instruction to use a new sterile applicator each time is non-negotiable for safety. The efficacy of the product is well-documented, but safety must come first.” – Dermatology Nurse Practitioner
  • “I experienced some initial redness and itching, which subsided after the first week. The gradual darkening of my lash line was a welcome effect. It’s crucial to understand this is a medication with biological activity, not a simple serum.” – Verified User